JNJ-18038683
|
化合物JNJ-18038683
|
851376-05-1
|
Elsulfavirine
|
Elsulfavirine
|
868046-19-9
|
GRP-60367
|
(4-((2-(2,5-二甲基苯氧基)乙基)氨基)哌啶-1-基)(吡啶-4-基)甲酮
|
1309241-34-6
|
Aumitin
|
AUMITIN
|
946293-78-3
|
RO-0335
|
RO0335
|
867365-76-2
|
LMPTP INHIBITOR 1 dihydrochloride
|
LMPTP INHIBITOR 1 dihydrochloride
|
2310135-46-5
|
Practolol
|
普拉洛爾
|
6673-35-4
|
RAD51-IN-17
|
RAD51-IN-17
|
2101739-18-6
|
(Rac)-Benpyrine
|
(Rac)-Benpyrine
|
1333714-43-4
|
4-amino-N-[4-(trifluoromethyl)phenyl]benzamide
|
4-amino-N-[4-(trifluoromethyl)phenyl]benzamide
|
1011244-72-6
|
DTZ
|
DTZ
|
344940-63-2
|
PS210
|
PS 210
|
1221962-86-2
|
CITCO
|
CITCO
|
338404-52-7
|
LY-2584702 (tosylate salt)
|
LY2584702 TOSYLATE
|
1082949-68-5
|
ROCK inhibitor-2
|
ROCK inhibitor-2
|
1127308-52-4
|
TM 5275
|
CS-2524
|
1103926-82-4
|
Carbamic acid, N-[(3R)-1-[[2-[[[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]amino]carbonyl]-4-pyridinyl]methyl]-3-piperidinyl]-, 1,1-dimethylethyl ester
|
Carbamic acid, N-[(3R)-1-[[2-[[[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]amino]carbonyl]-4-pyridinyl]methyl]-3-piperidinyl]-, 1,1-dimethylethyl ester
|
2448173-47-3
|
Bisindolylmaleimide VIII acetate
|
3-[1-(3-氨基丙基)-1H-吲哚-3-基]-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮單乙酸鹽
|
138516-31-1
|
PF 3845
|
PF 3845
|
1196109-52-0
|
Finasteride Carboxaldehyde
|
(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-二甲基-2-氧代乙基)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-十四氫-4a,6a-二甲基-2-氧代-1H-茚并[5,4-f]喹啉-7-羧酰胺
|
154387-61-8
|
Cotosudil
|
化合物 COTOSUDIL
|
1258833-31-6
|
CI 934
|
CI 934
|
91188-00-0
|
L-765314
|
L-765314
|
189349-50-6
|
Elexacaftor
|
ELEXACAFTOR
|
2216712-66-0
|
AZD-1390
|
CS-2816
|
2089288-03-7
|
CK1-IN-1
|
CK1-IN-1
|
1784751-20-7
|
RG120
|
艾伏尼布
|
1448347-49-6
|
7-chloroiMidazo[1,2-b]pyridazine
|
7-氯咪唑[1,2-B]噠嗪
|
1383481-11-5
|
Vodobatinib
|
K0706
|
1388803-90-4
|
AST 487
|
AST 487
|
630124-46-8
|
RESATORVID
|
瑞沙托維
|
243984-11-4
|
RO-31-8220
|
RO-31-8220
|
138489-18-6
|
Enasidenib
|
恩西地平
|
1446502-11-9
|
PVM/MA
|
PVM/MA共聚物
|
1644545-52-7
|
MS-402
|
MS-402
|
1672684-68-2
|
YB-0158
|
YB-0158
|
1144043-83-3
|
SR2516
|
PND1186
|
1061353-68-1
|
2-[2-Chloro-4-[(1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)methyl]-6-ethoxyphenoxy]aceticacidmethylester
|
CS-1226
|
431979-47-4
|
PKR-IN-1
|
PKR-IN-1
|
1260075-17-9
|
(±)-1-[(3aR*,4S*,9bS*)-4-(6-Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone
|
881639-98-1
|
881639-98-1
|
GR 125743
|
化合物GR 125743
|
148547-33-5
|
RGFP966
|
(2E)-N-(2-氨基-4-氟苯基)-3-[1-(3-苯基-2-丙烯-1-基)-1H-吡唑-4-基]-2-丙烯酰胺
|
1396841-57-8
|
AMG 487
|
AMG 487
|
473719-41-4
|
CRA-02478
|
PCI-24781
|
783355-60-2
|
ML 792
|
ML792
|
1644342-14-2
|
Pizuglanstat
|
化合物PIZUGLANSTAT
|
1244967-98-3
|
SGC 0946
|
SGC0946
|
1561178-17-3
|
(6S,9S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-2,9-dimethyl- 4,7-dioxo-8-(quinolin-8-ylmethyl)hexahydro-2H- pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide
|
1422253-37-9
|
1422253-37-9
|
JNJ 42041935
|
JNJ 42041935
|
1193383-09-3
|
2-[(Cyclopropylsulfonyl)amino]-N-(2-ethoxyphenyl)benzamide
|
2-[(Cyclopropylsulfonyl)amino]-N-(2-ethoxyphenyl)benzamide
|
1646499-97-9
|
CWP232228
|
化合物CWP232228
|
1144044-02-9
|
AZD0364
|
CS-2696
|
2097416-76-5
|
1(2H)-Phthalazinone, 4-[[3-[[3-[(cyclopropylamino)methyl]-1-azetidinyl]carbonyl]-4-fluorophenyl]methyl]-
|
Venadaparib
|
1681017-83-3
|
4-Pyrimidinamine, N-[[4-(1-methyl-1H-pyrazol-4-yl)phenyl]methyl]-6-[7-[3-(1-pyrrolidinyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-
|
化合物M4205
|
2590556-80-0
|
GSK-1070916
|
GSK1070916
|
942918-07-2
|
2-(1-Phenyl-cyclopropylamino)-pyrimidine-5-carboxylic acid hydroxyamide
|
N-羥基-2-[(1-苯基環(huán)丙基)氨基]-5-嘧啶甲酰胺
|
1375465-91-0
|
SAR-407899
|
6-(哌啶-4-氧基)異喹啉-1(2H)-酮鹽酸鹽
|
923262-96-8
|
UNC2025
|
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-環(huán)己醇
|
1429881-91-3
|
GNE7915
|
GNE7915
|
1351761-44-8
|
Volitinib
|
沃利替尼
|
1313725-88-0
|
NG25
|
N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-(1H-吡咯并[2,3-B]吡啶-4-基氧基)苯甲酰胺
|
1315355-93-1
|
BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)-
|
氟馬替尼
|
895519-90-1
|
NVP-BGJ398
|
FGFR抑制劑(NVP-BGJ398)
|
872511-34-7
|
X-376
|
恩沙替尼
|
1365267-27-1
|
AZD8055
|
AZD8055
|
1009298-09-2
|
A-83-01
|
3-(6-甲基-2-吡啶基)-N-苯基-4-(4-喹啉基)-1H-吡唑-1-硫代甲酰胺
|
909910-43-6
|
ORY-2001
|
VAFIDEMSTAT
|
1357362-02-7
|
GS-9876 (lanraplenib)
|
GS-9876
|
1800046-95-0
|
PEXMETINIB
|
PEXMETINIB
|
945614-12-0
|
PF 573228
|
6-[(4-((3-(甲磺?;?芐基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氫-1H-喹啉-2-酮
|
869288-64-2
|
AD80
|
AD80
|
1384071-99-1
|
Cerdulatinib
|
賽度替尼
|
1198300-79-6
|
ACY1215
|
ACY1215
|
1316214-52-4
|
Emedastine
|
依美司丁
|
87233-61-2
|
ROSCOVITINE
|
細胞周期蛋白B激酶抑制劑
|
186692-46-6
|
5-AMINO-2-(4-TERT-BUTYLPHENOXY)PYRIDINE
|
6-[4-(叔丁基)苯氧基]吡啶-3-胺
|
218457-67-1
|
GSK2982772
|
GSK2982772
|
1622848-92-3
|
PRN-1371
|
PRN1371
|
1802929-43-6
|
WYE-354
|
4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-嗎啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯
|
1062169-56-5
|
AUZ 454
|
K03861
|
853299-07-7
|
1-benzyl-N-(furan-2-ylmethyl)benzimidazol-2-amine
|
AC1903
|
831234-13-0
|
SHP-099
|
SHP-099游離
|
1801747-42-1
|
SLx-2119
|
2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-異丙基乙酰胺
|
911417-87-3
|
γ-Secretase Inhibitor XXI
|
N-[(1S)-2-[[(3S)-2,3-二氫-1-甲基-2-氧代-5-苯基-1H-1,4-苯并二氮雜卓-3-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟苯乙酰胺
|
209986-17-4
|
Tapinarof
|
苯烯莫德
|
79338-84-4
|
Ponatinib
|
帕納替尼
|
943319-70-8
|
PD173955
|
6-(2,6-二氯苯基)-8-甲基-2-[[3-(甲硫基)苯基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮
|
260415-63-2
|
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-
|
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-
|
2160546-07-4
|
ALK/IGF1R inhibitor
|
AZD3463
|
1356962-20-3
|
PP242
|
PP242
|
1092351-67-1
|
CYC-065
|
CYC-065
|
1070790-89-4
|
GSK2334470
|
GSK2334470
|
1227911-45-6
|
(S)-2-(6-bromobenzo[d][1,3]dioxol-5-yl)-N-(4-cyanophenyl)-1-(1-cyclohexylethyl)-1H-benzo[d]imidazole-5-carboxamide
|
(S)-2-(6-溴苯并[D][1,3]二氧雜環(huán)戊烯-5-基)-N-(4-氰基苯基)-1-(1-環(huán)己基乙基)-1H-苯并[D]咪唑-5-甲酰胺
|
2100284-59-9
|
SGI-1776
|
SGI-1776
|
1025065-69-3
|
PD 166285
|
6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮鹽酸鹽
|
212391-63-4
|
H3B-6527
|
H3B-6527
|
1702259-66-2
|
GDC-0623
|
GDC-0623
|
1168091-68-6
|
ALK inhibitor 2
|
2-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺
|
761438-38-4
|
MLN-8237
|
阿立塞替
|
1028486-01-2
|
AZD2858
|
AZD2858
|
486424-20-8
|